📬 Free daily newsletter

Biotech news that matters.
In 5 minutes.

Join 2,700+ biotech and pharma professionals who start their morning with the deals, trials, and decisions shaping the industry.

What lands in your inbox

T
TLDR Biotech
Your daily biotech briefing
🧬 Eli Lilly acquires Orna Therapeutics for $2.4B — in vivo CAR-T tech targeting autoimmunity
💊 AstraZeneca + CSPC partner on obesity — $1.2B upfront + $18.5B in biobucks
🏭 Vetter Pharma invests €480M for new German CDMO facility — targeting 2031 launch
📊 Roche's CT-388 hits 22.5% weight loss in Phase 2 obesity trial

Why 2,700+ readers start here

⚡

5-minute read

Get the signal without the noise. Curated, not aggregated.

🎯

Actually relevant

M&A, trials, FDA decisions, funding — what moves the market.

🧠

Written by someone who gets it

Not AI summaries. Human curation from an industry insider.

📅

Daily consistency

Every weekday morning. Never miss a deal or decision.

2,700+

biotech & pharma professionals subscribe

Anis Fahandej-Sadi

"I built this newsletter because I was tired of digging through 10 sources every morning. Now I do the digging — so you don't have to."

Anis Fahandej-Sadi

M.Sc. Chemistry · Ex-Cytiva · Ex-OmniaBio

Join the briefing.

Free. Daily. Actually useful.